BETA BIONICS

Serial Number 99120587
645

Registration Progress

Application Filed
Apr 4, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Apr 16, 2026 88 days

Trademark Image

BETA BIONICS

Basic Information

Serial Number
99120587
Filing Date
April 4, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
645
Status Date
Jan 16, 2026
Application
Pending
Classes
010 044

Rights Holder

Beta Bionics, Inc.

03
Address
300 Baker Avenue
Suite 301
Concord, MA 01742

Ownership History

Beta Bionics, Inc.

Original Applicant
03
Concord, MA

Legal Representation

Attorney
KAVEH NEWMEN

USPTO Deadlines

Next Deadline
88 days remaining
Final Refusal E-Mailed
Due Date
April 16, 2026
Extension Available
Until July 16, 2026

Application History

14 events
Date Code Type Description Documents
Jan 16, 2026 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 16, 2026 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 16, 2026 CNFR R FINAL REFUSAL WRITTEN Loading...
Dec 3, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 3, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 3, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 3, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 15, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 4, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 4, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Devices for controlling, raising, and lowering blood glucose for medical purposes.
First Use Anywhere: Aug 25, 2016
First Use in Commerce: Aug 25, 2016
Class 044
Providing medical information in the field of diabetes and blood glucose control for the purpose of promoting healthcare equity.
First Use Anywhere: Aug 25, 2016
First Use in Commerce: Aug 25, 2016

Additional Information

Design Mark
The mark consists of the stylized wording "Beta Bionics". The letters "B" in both "Beta" and "Bionics" are stylized to resemble the Greek letter beta (β). The letter “A” in "Beta" is creatively designed to resemble the shape of a fish, formed with a curved body and a tail-like crossbar. The remaining letters appear in a clean, rounded, modern sans-serif typeface.

Classification

International Classes
010 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIONIC